| 000 | 01515 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516043322.0 | ||
| 264 | 0 | _c20120515 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1533-712X | ||
| 024 | 7 |
_a10.1097/JCP.0b013e318221b408 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, Maxine X | |
| 245 | 0 | 0 |
_aPlasma olanzapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1999-2009. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cAug 2011 |
||
| 300 |
_a411-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBenzodiazepines _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBowskill, Sally | |
| 700 | 1 | _aCouchman, Lewis | |
| 700 | 1 | _aLay, Victoria | |
| 700 | 1 | _aTaylor, David | |
| 700 | 1 | _aSpencer, Edgar Pathrose | |
| 700 | 1 | _aFlanagan, Robert James | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 31 _gno. 4 _gp. 411-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/JCP.0b013e318221b408 _zAvailable from publisher's website |
| 999 |
_c20948794 _d20948794 |
||